AbbVie

12 atoms · 跨 6 天 · 首见 2026-05-26 · 最近 2026-07-01

三色: 🟦 fact 12 · 🟥 take 0 · stance ▲3/▼0/◆2

来源: X 12

时态: fresh:12

标签: 好信源:9 · 好数字:6

事实 (fact) (12)

• 2026-06-19 · 交易条款：收购价
  UNDER THE TERMS OF THE DEAL BEING DISCUSSED, ABBVIE WOULD PAY APOGEE SHAREHOLDERS $10.9BN IN CASH
  tags: 好数字·好信源 · → daily
  value: qty=$10.9B · date=2026-06-19 · direction=na
• 2026-05-27 · 中国批准保妥适用于额头纹
  AbbVie's Allergan Aesthetics recently held a conference in Shanghai to mark the China approval of Botox for forehead lines, its fourth aesthetic indication in the market.
  tags: 好信源·好数字 · → daily
  value: date=2026-05-27
• 2026-05-26 · 保妥适在中国获批治疗额头纹，是其在中国的第四个美学适应症
  AbbVie's Allergan Aesthetics recently held a conference in Shanghai to mark the China approval of Botox for forehead lines, its fourth aesthetic indication in the market.
  tags: 好数字·好信源 · → daily
  value: qty=第四个 · date=2026-05-26
• 2026-07-01 · 被美国国会调查中国药物试验活动
  US lawmakers begin an investigation into the China drug trial activities of Merck & Co. and AbbVie.
  tags: 好信源 · → daily
• 2026-06-23 · 获欧盟批准Mavyret用于丙肝治疗
  ABBVIE GETS EU APPROVAL OF MAVIRET FOR HEPATITIS C TREATMENT
  tags: 好信源 · → daily
• 2026-06-22 · 收购APGE
  AbbVie agreed to buy Apogee Therapeutics for $10.9 billion
  tags: 好数字 · → daily
  value: qty=$10.9B · date=2026-06-22
• 2026-06-19 · 收购Apogee状态
  Abbvie Closes in on Nearly $11Bn Deal for Biotech Apogee Therapeutics
  tags: 好信源 · → daily
  value: direction=closing in
• 2026-05-27 · FDA approval
  FDA approves AbbVie's pivekimab sunirine-PVZY for blastic plasmacytoid dendritic cell neoplasm
  tags: 好信源 · → daily
  value: date=2026-05-27
• 2026-06-22 · 收购Apogee金额
  AbbVie 109亿收购Apogee(溢价52%)
  tags: 好数字 · → daily
  value: qty=109亿 · currency=USD
• 2026-06-22 · 收购Apogee溢价
  AbbVie 109亿收购Apogee(溢价52%)
  tags: 好数字 · → daily
  value: qty=52%
• 2026-05-26 · 旗下Allergan美学事业部在上海举行会议，庆祝保妥适治疗额头纹在中国获批
  AbbVie's Allergan Aesthetics recently held a conference in Shanghai to mark the China approval of Botox for forehead lines, its fourth aesthetic indication in the market.
  tags: 好信源 · → daily
  value: date=2026-05-26
• 2026-05-26 · 在上次会议中解读了一套针对中国患者面部上三分之一年轻化治疗的循证临床建议
  A set of evidence-based clinical recommendations developed specifically for upper face rejuvenation treatment in Chinese patients was also interpreted at the event.
  tags: 好信源 · → daily
  value: date=2026-05-26

时间轴 (近 20)

• 2026-07-01 · fact · 被美国国会调查中国药物试验活动 · → daily
• 2026-06-23 · fact · 获欧盟批准Mavyret用于丙肝治疗 · → daily
• 2026-06-22 · fact · 收购Apogee金额 · → daily
• 2026-06-22 · fact · 收购Apogee溢价 · → daily
• 2026-06-22 · fact · 收购APGE · → daily
• 2026-06-19 · fact · 交易条款：收购价 · → daily
• 2026-06-19 · fact · 收购Apogee状态 · → daily
• 2026-05-27 · fact · 中国批准保妥适用于额头纹 · → daily
• 2026-05-27 · fact · FDA approval · → daily
• 2026-05-26 · fact · 旗下Allergan美学事业部在上海举行会议，庆祝保妥适治疗额头纹在中国获批 · → daily
• 2026-05-26 · fact · 保妥适在中国获批治疗额头纹，是其在中国的第四个美学适应症 · → daily
• 2026-05-26 · fact · 在上次会议中解读了一套针对中国患者面部上三分之一年轻化治疗的循证临床建议 · → daily

← 实体目录 · 系统日志